Test Price
2,800 AEDโ Home Collection Available
SOX17 Gene Vesicoureteral Reflux Type 3 Genetic Test in UAE | AED 2800
Executive Summary & Core Metrics
The SOX17 gene sequencing test using Next-Generation Sequencing (NGS) is a precise diagnostic assay approved by the Dubai Health Authority and ISO 9001:2015 certified. The test achieves 99.9% diagnostic sensitivity for detecting SOX17 gene mutations associated with Vesicoureteral Reflux Type 3, enabling early therapeutic intervention and improved quality of life. We offer paid home sample collection under certified cold-chain transport protocols, with mandatory genetic counselling sessions for accurate result interpretation.
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
SOX17 gene sequencing identifies pathogenic variants causing Vesicoureteral Reflux Type 3 (VUR3), aiding in early diagnosis and personalized management of this congenital anomaly. This NGS-based test detects single nucleotide variants, small indels, and copy number variations with high precision across all coding exons. The methodology employs targeted enrichment and high-depth sequencing to ensure comprehensive coverage of the SOX17 gene locus.
| Feature | Our Test (NGS) | Conventional Sanger Sequencing |
|---|---|---|
| Precision & Coverage | Full gene coverage, all exons, >99% analytical sensitivity | Limited to targeted exons, potential for missed variants |
| Turnaround Time | 3โ4 weeks | 4โ6 weeks (fragmented testing) |
| Regulatory & ISO | ISO 9001:2015, DHA compliant | Varies, often non-accredited |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: "NGS-based sequencing of SOX17 provides exceptional diagnostic resolution for VUR3, yet it must be integrated with renal imaging and urodynamic studies for a complete clinical picture. Family cascade screening and pedigree analysis remain essential components of the genetic counselling process. A multidisciplinary approach involving nephrology and paediatric urology ensures optimal long-term outcomes."
Advisory on Medication & Clinical Management
โ ๏ธ Clinical Advisory: Do not discontinue or modify prescribed antibiotic prophylaxis or any other medications without consulting your treating physician. Genetic test results are intended to inform clinical decision-making, not to replace ongoing medical management.
Exclusion Criteria & Emergency Red Flags
- Pregnancy (relative contraindication; genetic counselling advised).
- Acute febrile illness or severe urinary tract infection at time of sampling.
- Lack of consent for mandatory pre-test genetic counselling.
- ER Red Flags: Sudden flank pain, high fever, hematuria, or signs of sepsisโseek immediate emergency care; testing can be deferred.
Patient FAQ & Clinical Guidance
1. What is the SOX17 gene test for Vesicoureteral Reflux Type 3?
Snippet: The SOX17 gene NGS test detects mutations in the SOX17 gene responsible for Vesicoureteral Reflux Type 3, a congenital urinary tract anomaly. It helps confirm diagnosis, assess familial risk, and guide surgical or conservative management, with results ready in 3โ4 weeks.
2. How is the sample collected and what is the turnaround time?
Snippet: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection service collects blood in a certified cold-chain kit; turnaround time is 3โ4 weeks. Patients receive a collection window of 8 AM to 11 PM for convenience.
3. Is genetic counseling required?
Snippet: Yes, a mandatory pre-test genetic counselling session must review family history and construct a pedigree chart before sample collection. This ensures informed consent and accurate interpretation of SOX17 variants.
4. What do the results mean for my family?
Snippet: A positive result confirms a pathogenic variant in SOX17, indicating VUR3 with implications for first-degree relatives. Cascade screening and reproductive counselling are recommended for at-risk family members.
5. Is this test covered by insurance?
Snippet: Insurance coverage varies by provider. Direct billing verification is available via WhatsApp at +971 54 548 8731. Please contact us prior to testing to confirm your eligibility and coverage details.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with UAE federal data protection and healthcare privacy statutes. All genetic data is processed and stored under the provisions of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data minimization, and secure processing are enforced at every stage of the testing workflow. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is licensed by the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | SOX17 Gene Vesicoureteral Reflux Type 3 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next-Generation Sequencing (NGS) โ Targeted gene sequencing |
| ICD-10-CM Code | Q62.7 |
| LOINC Code | 21665-7 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians